A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Nektar Therapeutics stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 12,932 shares of NKTR stock, worth $12,932. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,932
Previous 12,838 0.73%
Holding current value
$12,932
Previous $15,000 6.67%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1.11 - $1.48 $104 - $139
94 Added 0.73%
12,932 $16,000
Q2 2024

Aug 12, 2024

BUY
$0.9 - $1.83 $873 - $1,775
970 Added 8.17%
12,838 $15,000
Q1 2024

May 09, 2024

BUY
$0.49 - $0.96 $5,815 - $11,393
11,868 New
11,868 $11,000
Q3 2023

Nov 08, 2023

BUY
$0.51 - $1.05 $19,677 - $40,513
38,584 New
38,584 $23,000

Others Institutions Holding NKTR

About NEKTAR THERAPEUTICS


  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $187M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Vanguard Personalized Indexing Management, LLC Portfolio

Follow Vanguard Personalized Indexing Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.